Ameritas Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
11,970
+75
| +0.6% | +$7.96K | 0.04% | 534 |
|
|
2025
Q1 | $1.48M | Sell |
11,895
-214
| -2% | -$26.6K | 0.05% | 444 |
|
|
2024
Q4 | $1.49M | Sell |
12,109
-561
| -4% | -$69.1K | 0.05% | 471 |
|
|
2024
Q3 | $1.41M | Sell |
12,670
-739
| -6% | -$82.3K | 0.05% | 501 |
|
|
2024
Q2 | $1.43M | Sell |
13,409
-492
| -4% | -$52.5K | 0.05% | 456 |
|
|
2024
Q1 | $1.67M | Hold |
13,901
| – | – | 0.06% | 409 |
|
|
2023
Q4 | $1.71M | Sell |
13,901
-259
| -2% | -$31.9K | 0.06% | 362 |
|
|
2023
Q3 | $1.83M | Sell |
14,160
-1,870
| -12% | -$242K | 0.07% | 292 |
|
|
2023
Q2 | $1.99M | Hold |
16,030
| – | – | 0.07% | 296 |
|
|
2023
Q1 | $2.35M | Sell |
16,030
-266
| -2% | -$38.9K | 0.09% | 232 |
|
|
2022
Q4 | $2.53M | Buy |
16,296
+176
| +1% | +$27.4K | 0.1% | 211 |
|
|
2022
Q3 | $2.15M | Sell |
16,120
-500
| -3% | -$66.6K | 0.1% | 207 |
|
|
2022
Q2 | $2.59M | Buy |
16,620
+184
| +1% | +$28.7K | 0.11% | 170 |
|
|
2022
Q1 | $2.56M | Hold |
16,436
| – | – | 0.09% | 234 |
|
|
2021
Q4 | $2.09M | Buy |
16,436
+192
| +1% | +$24.5K | 0.07% | 315 |
|
|
2021
Q3 | $2.12M | Hold |
16,244
| – | – | 0.08% | 285 |
|
|
2021
Q2 | $2.89M | Buy |
16,244
+746
| +5% | +$133K | 0.1% | 198 |
|
|
2021
Q1 | $2.55M | Buy |
15,498
+100
| +0.6% | +$16.4K | 0.1% | 225 |
|
|
2020
Q4 | $2.54M | Sell |
15,398
-303
| -2% | -$50K | 0.12% | 199 |
|
|
2020
Q3 | $2.24M | Buy |
+15,701
| New | +$2.24M | 0.1% | 199 |
|